Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial. Shabir A Madhi , Gaurav Kwatra , Simone I Richardson , Anthonet L Koen , Vicky Baillie , Clare L Cutland , Lee Fairlie , Sherman D Padayachee , Keertan Dheda , Shaun L Barnabas , Qasim Ebrahim Bhorat , Carmen Briner , Khatija Ahmed , Parvinder K Aley , Sutika Bhikha , A E Bhorat , Aliasgar Esmail , Elizea Horne , Haajira Kaldine , Christian K Mukendi , Vimbai Sharon Madzorera , Nelia P Manamela , Mduduzi Masilela , S Tandile Hermanus , Thopisang Motlou , Nonkululeko Mzindle , Suzette Oelofse , Faeezah Patel , Sarah Rhead , Lindie Rossouw , Carol Taoushanis , Samuel van Eck , Teresa Lambe , Sarah C Gilbert , Andrew J Pollard , Penny L Moore , Alane Izu The Lancet. Infectious diseases（2023）
摘要
For the Zulu translation of the abstract see Supplementary Materials section.
更多 查看译文
关键词
hybrid humoral immunity, vaccine, humoral immunity, vaccination, post-hoc
AI 理解论文
溯源树
样例
